CATALOGO DEI PRODOTTI DELLA RICERCA

Sfoglia per Autore  

Opzioni
Mostrati risultati da 61 a 80 di 251
Titolo Data di pubblicazione Autore(i) File
Oral Ondansetron is Highly Active as Rescue Antiemetic Treatment for Moderately Emetogenic Chemotherapy: Results of a Randomized Phase II Study 1-gen-2008 Fabi, A; Ciccarese, M; Metro, G; Bavarese, A; Giannarelli, D; Nuzzo, C; Russillo, M; Sperduti, I; Carbone, I; Bria, Emilio; Cognetti, F.
Thalidomide In Small-Cell Lung Cancer: Is It A Tombstone? 1-gen-2008 Rossi, A; Bria, Emilio; Gridelli, C.
Progression-free survival as primary endpoint in advanced non-small-cell lung cancer: does the size matter? 1-gen-2008 Di Maio, M; Bria, Emilio; Rossi, A; Perrone, F.
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer. 1-gen-2008 Bria, Emilio; Visca, P; Novelli, F; Casini, B; Diodoro, Mg; Perrone Donnorso, R; Botti, C; Sperduti, I; Facciolo, F; Milella, M; Cecere, Fl; Cognetti, F; Mottolese, M.
Cardiotoxicity and Incidence Of Brain Metastases After Adjuvant Trastuzumab for Early Breast Cancer: The Dark Side of the Moon? A Meta-Analysis of The Randomized Trials. 1-gen-2008 Bria, Emilio; Cuppone, F; Fornier, M; Nisticò, C; Carlini, P; Milella, M; Sperduti, I; Terzoli, E; Cognetti, F; Giannarelli, D.
Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials 1-gen-2008 Cuppone, F; Bria, Emilio; Carlini, P; Micella, M; Felici, A; Sperduti, I; Nisticò, C; Terzoli, E; Cognetti, F; Giannarelli, G.
Do adjuvant aromatase inhibitors increase the cardiovascular risk in post-menopausal women with early breast cancer? Meta-analysis of randomized trials 1-gen-2008 Cuppone, F; Bria, Emilio; Verma, S; Pritchard, Ki; Gandhi, S; Carlini, P; Milella, M; Nisticò, C; Terzoli, E; Cognetti, F; Giannarelli, D.
Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer 1-gen-2008 Rossi, A; Bria, Emilio; Maione, P; Palazzolo, G; Falanga, M; Gridelli, C.
Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer? Meta-analysis of randomized trials. 1-gen-2009 Bria, Emilio; Cuppone, F; Giannarelli, D; Milella, M; Ruggeri, Em; Sperduti, I; Pinnarò, P; Terzoli, E; Cognetti, F; Carlini, P.
Novel Clinical Prognostic Score Incorporating the Number of Resected Lymph-Nodes to Predict Recurrence and Survival in Non-Small-Cell Lung Cancer. 1-gen-2009 Bria, Emilio; Milella, M; Sperduti, I; Alessandrini, G; Visca, P; Corzani, F; Giannarelli, D; Cerasoli, V; Cuppone, F; Cecere, Fl; Marchetti, A; Sacco, R; Mucilli, F; Malatesta, S; Guetti, L; Vitale, L; Ceribelli, A; Rinaldi, M; Terzoli, E; Cognetti, F; Facciolo, F.
Trastuzumab plus weekly epirubicin and paclitaxel for locally advanced and metastatic breast cancer: preliminary results of a feasibility-phase II study aimed to cardiotoxicity 1-gen-2009 Nisticò, C; Bria, Emilio; Vaccaro, V; Cuppone, F; Fornier, M; Sperduti, I; Carpino, A; Izzo, F; Troppa, F; Cognetti, F; Terzoli, E.
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. 1-gen-2009 Pino, Ms; Milella, M; Gelibter, A; Sperduti, I; De Marco, S; Nuzzo, C; Bria, Emilio; Carpanese, L; Ruggeri, Em; Carlini, P; Cognetti, F.
Cetuximab for Metastatic Colo-rectal Cancer 1-gen-2009 Bria, Emilio; Cuppone, F; Di Maio, M.
Magnitude of Benefit of Adjuvant Chemotherapy for Non-Small-Cell Lung Cancer: Meta-Analysis of Randomized Clinical Trials. 1-gen-2009 Bria, Emilio; Gralla, Rj; Raftopoulos, H; Cuppone, F; Milella, M; Sperduti, I; Carlini, P; Terzoli, E; Cognetti, F; Giannarelli, D.
Targeting targeted agents: open issues for clinical trial design. 1-gen-2009 Bria, Emilio; Di Maio, M; Carlini, P; Cuppone, F; Giannarelli, D; Cognetti, F; Milella, M.
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials. 1-gen-2010 Cuppone, F; Bria, Emilio; Giannarelli, D; Vaccaro, V; Milella, M; Nisticò, C; Ruggeri, Em; Sperduti, I; Bracarda, S; Pinnarò, P; Lanzetta, G; Muti, P; Cognetti, F; Carlini, P.
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials 1-gen-2010 Loupakis, F; Bria, Emilio; Vaccaro, V; Cuppone, F; Milella, M; Carlini, P; Cremolini, C; Salvatore, L; Falcone, A; Muti, P; Sperduti, I; Giannarelli, D; Cognetti, F.
Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia multinational consensus conference. 1-gen-2010 Roila, F; Herrstedt, J; Aapro, M; Gralla, Rj; Einhorn, L; Ballatori, E; Bria, Emilio; Clark Snow, Ra; Espersen, Bt; Feyer, P; Grunberg, Sm; Hesketh, Pj; Jordan, K; Kris, M; Maranzano, E; Molassiotis, A; Morrow, G; Olver, I; Rapoport, Bl; Rittenberg, C; Saito, M; Tonato, M; Warr, D; On behalf of the ESMO/MASCC Guidelines Working, Group
Early recurrence risk: aromatase inhibitors versus tamoxifen. 1-gen-2010 Bria, Emilio; Carlini, P; Cuppone, F; Vaccaro, V; Milella, M; Cognetti, F.
Ricerche Bibliografiche e Utilità del Web [Capitolo 3] 1-gen-2010 Bria, Emilio
Mostrati risultati da 61 a 80 di 251
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile